Prime Movers Lab Fund I LP - 06 Sep 2023 Form 4 Insider Report for Vaxxinity, Inc.

Reporting relationship: 10%+ Owner
Issuer ticker: N/A
Reported as of: 06 Sep 2023
Net transaction value: -$168,588
SEC form: 4
Accepted by SEC: 08 Sep 2023, 18:05:17 UTC
Prior SEC filing: 09 Jun 2023
Next SEC filing: 11 Sep 2023
Source filing: View source filing
Reporting owner signature: Prime Movers Lab Fund I LP /s/ Taylor Frankel, Authorized Person

Key filing fact

Prime Movers Lab Fund I LP filed Form 4 for Vaxxinity, Inc. on 08 Sep 2023.

Key facts

This page summarizes Prime Movers Lab Fund I LP's Form 4 filing for Vaxxinity, Inc..
15 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 08 Sep 2023, 18:05.

Change

Previous filing in this sequence was filed on 09 Jun 2023.
Current net transaction value: -$168,588.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VAXX transaction

Class A Common Stock

Sale

Transaction value: $2,355
Shares: -1,251
Change %: -0.06%
Price: $1.88
Shares after: 2,063,776
Date: 06 Sep 2023
Ownership: Held by COVAXX PML SPV 1 LP
Footnotes: F1, F2, F7

VAXX transaction

Class A Common Stock

Sale

Transaction value: $9,991
Shares: -5,308
Change %: -0.06%
Price: $1.88
Shares after: 8,759,064
Date: 06 Sep 2023
Ownership: Direct
Footnotes: F1, F3, F7

VAXX transaction

Class A Common Stock

Sale

Transaction value: $954
Shares: -507
Change %: -0.06%
Price: $1.88
Shares after: 835,992
Date: 06 Sep 2023
Ownership: Held by COVAXX PML SPV 2 LP
Footnotes: F1, F4, F7

VAXX transaction

Class A Common Stock

Sale

Transaction value: $1,679
Shares: -892
Change %: -0.06%
Price: $1.88
Shares after: 1,472,208
Date: 06 Sep 2023
Ownership: Held by COVAXX PML SPV 3 LP
Footnotes: F1, F5, F7

VAXX transaction

Class A Common Stock

Sale

Transaction value: $4,120
Shares: -2,189
Change %: -0.06%
Price: $1.88
Shares after: 3,612,849
Date: 06 Sep 2023
Ownership: Held by Prime Movers Growth Fund 1 LP
Footnotes: F1, F6, F7

VAXX transaction

Class A Common Stock

Sale

Transaction value: $8,554
Shares: -4,786
Change %: -0.23%
Price: $1.79
Shares after: 2,058,990
Date: 07 Sep 2023
Ownership: Held by COVAXX PML SPV 1 LP
Footnotes: F2, F7, F8

VAXX transaction

Class A Common Stock

Sale

Transaction value: $36,302
Shares: -20,312
Change %: -0.23%
Price: $1.79
Shares after: 8,738,752
Date: 07 Sep 2023
Ownership: Direct
Footnotes: F3, F7, F8

VAXX transaction

Class A Common Stock

Sale

Transaction value: $3,465
Shares: -1,939
Change %: -0.23%
Price: $1.79
Shares after: 834,053
Date: 07 Sep 2023
Ownership: Held by COVAXX PML SPV 2 LP
Footnotes: F4, F7, F8

VAXX transaction

Class A common stock

Sale

Transaction value: $6,100
Shares: -3,413
Change %: -0.23%
Price: $1.79
Shares after: 1,468,795
Date: 07 Sep 2023
Ownership: Held by COVAXX PML SPV 3 LP
Footnotes: F5, F7, F8

VAXX transaction

Class A common stock

Sale

Transaction value: $14,973
Shares: -8,378
Change %: -0.23%
Price: $1.79
Shares after: 3,604,471
Date: 07 Sep 2023
Ownership: Held by Prime Movers Growth Fund 1 LP
Footnotes: F6, F7, F8

VAXX transaction

Class A common stock

Sale

Transaction value: $9,871
Shares: -5,911
Change %: -0.29%
Price: $1.67
Shares after: 2,053,079
Date: 08 Sep 2023
Ownership: Held by COVAXX PML SPV 1 LP
Footnotes: F2, F7, F9

VAXX transaction

Class A common stock

Sale

Transaction value: $41,899
Shares: -25,089
Change %: -0.29%
Price: $1.67
Shares after: 8,713,663
Date: 08 Sep 2023
Ownership: Direct
Footnotes: F3, F7, F9

VAXX transaction

Class A Common Stock

Sale

Transaction value: $4,000
Shares: -2,395
Change %: -0.29%
Price: $1.67
Shares after: 831,658
Date: 08 Sep 2023
Ownership: Held by COVAXX PML SPV 2 LP
Footnotes: F4, F7, F9

VAXX transaction

Class A common stock

Sale

Transaction value: $7,042
Shares: -4,217
Change %: -0.29%
Price: $1.67
Shares after: 1,464,578
Date: 08 Sep 2023
Ownership: Held by COVAXX PML SPV 3 LP
Footnotes: F5, F7, F9

VAXX transaction

Class A common stock

Sale

Transaction value: $17,283
Shares: -10,349
Change %: -0.29%
Price: $1.67
Shares after: 3,594,122
Date: 08 Sep 2023
Ownership: Held by Prime Movers Growth Fund 1 LP
Footnotes: F6, F7, F9

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 9 footnotes

Footnote F1

The price of $1.8823 per share represents a weighted average of purchase prices ranging from $1.85 to $1.94 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

Footnote F2

Held by COVAXX PML SPV 1 LP ("PML SPV 1"). Prime Movers Lab GP I LLC ("PML GP I") is the general partner of Prime Movers Lab Fund I LP ("PML") and PML SPV 1.

Footnote F3

Held by PML. PML GP I is the general partner of PML.

Footnote F4

Held by COVAXX PML SPV 2 LP ("PML SPV 2"). Prime Movers Lab GP II LLC ("PML GP II") is the general partner of PML SPV 2.

Footnote F5

Held by COVAXX PML SPV 3 LP ("PML SPV 3"). PML GP II is the general partner of PML SPV 3.

Footnote F6

Held by Prime Movers Growth Fund 1 LP ("PMG"). Prime Movers Growth GP I LLC ("PMG GP") is the general partner of PMG.

Footnote F7

Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein.

Footnote F8

The price of $1.7872 per share represents a weighted average of purchase prices ranging from $1.75 to $1.86 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

Footnote F9

The price of $1.6700 per share represents a weighted average of purchase prices ranging from $1.60 to $1.82 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.